Long-Term Effects of a Long-Acting β<sub>2</sub>-Adrenoceptor Agonist, Salmeterol, on Airway Hyperresponsiveness in Patients with Mild AsthmaDavid Cheung, Peter Sterk, Elisabeth H. Bel et al.|New England Journal of Medicine|1992Cited by 454
The development of the ‘Quality-of-Life for Respiratory Illness Questionnaire (QOL-RIQ)’: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung diseaseA. Rianne Maillé, Ad A. Kaptein, Cejóma J. M. Koning et al.|Respiratory Medicine|1997Cited by 125
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.EH Bel, Peter Sterk, Aeilko H. Zwinderman et al.|Thorax|1991Cited by 88